Discounted Cash Flow (DCF) Analysis Levered
DENTSPLY SIRONA Inc. (XRAY)
$38.2
-0.24 (-0.62%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | 3,993.40 | 3,986.30 | 4,029.20 | 3,342 | 4,251 | 4,368.35 | 4,488.94 | 4,612.86 | 4,740.20 | 4,871.06 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | 601.90 | 499.80 | 632.80 | 635 | 657 | 679.47 | 698.22 | 717.50 | 737.30 | 757.66 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | -151 | -188 | -122.90 | -87 | -142 | -152.82 | -157.03 | -161.37 | -165.82 | -170.40 |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | 450.90 | 311.80 | 509.90 | 548 | 515 | 526.65 | 541.19 | 556.13 | 571.48 | 587.26 |
Weighted Average Cost Of Capital
Share price | $ 38.2 |
---|---|
Beta | 0.914 |
Diluted Shares Outstanding | 219.20 |
Cost of Debt | |
Tax Rate | 24.69 |
After-tax Cost of Debt | 1.81% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 7.934 |
Total Debt | 2,290 |
Total Equity | 8,373.44 |
Total Capital | 10,663.44 |
Debt Weighting | 21.48 |
Equity Weighting | 78.52 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | 3,993.40 | 3,986.30 | 4,029.20 | 3,342 | 4,251 | 4,368.35 | 4,488.94 | 4,612.86 | 4,740.20 | 4,871.06 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | 601.90 | 499.80 | 632.80 | 635 | 657 | 679.47 | 698.22 | 717.50 | 737.30 | 757.66 |
Capital Expenditure | -151 | -188 | -122.90 | -87 | -142 | -152.82 | -157.03 | -161.37 | -165.82 | -170.40 |
Free Cash Flow | 450.90 | 311.80 | 509.90 | 548 | 515 | 526.65 | 541.19 | 556.13 | 571.48 | 587.26 |
WACC | ||||||||||
PV LFCF | 358.50 | 345.52 | 333.02 | 320.96 | 309.34 | |||||
SUM PV LFCF | 2,297.31 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 6.62 |
Free cash flow (t + 1) | 599 |
Terminal Value | 12,965.40 |
Present Value of Terminal Value | 9,410.06 |
Intrinsic Value
Enterprise Value | 11,707.37 |
---|---|
Net Debt | 1,951 |
Equity Value | 9,756.37 |
Shares Outstanding | 219.20 |
Equity Value Per Share | 44.51 |